A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support
- PMID: 37195444
- PMCID: PMC10959568
- DOI: 10.1007/s00259-023-06259-4
A machine learning method integrating ECG and gated SPECT for cardiac resynchronization therapy decision support
Abstract
Purpose: Cardiac resynchronization therapy (CRT) has been established as an important therapy for heart failure. Mechanical dyssynchrony has the potential to predict responders to CRT. The aim of this study was to report the development and the validation of machine learning models which integrate ECG, gated SPECT MPI (GMPS), and clinical variables to predict patients' response to CRT.
Methods: This analysis included 153 patients who met criteria for CRT from a prospective cohort study. The variables were used to model predictive methods for CRT. Patients were classified as "responders" for an increase of LVEF ≥ 5% at follow-up. In a second analysis, patients were classified as "super-responders" for an increase of LVEF ≥ 15%. For ML, variable selection was applied, and Prediction Analysis of Microarrays (PAM) approach was used to model response while Naïve Bayes (NB) was used to model super-response. These ML models were compared to models obtained with guideline variables.
Results: PAM had AUC of 0.80 against 0.72 of partial least squares-discriminant analysis with guideline variables (p = 0.52). The sensitivity (0.86) and specificity (0.75) were better than for guideline alone, sensitivity (0.75) and specificity (0.24). Neural network with guideline variables was better than NB (AUC = 0.93 vs. 0.87) however without statistical significance (p = 0.48). Its sensitivity and specificity (1.0 and 0.75, respectively) were better than guideline alone (0.78 and 0.25, respectively).
Conclusions: Compared to guideline criteria, ML methods trended toward improved CRT response and super-response prediction. GMPS was central in the acquisition of most parameters. Further studies are needed to validate the models.
Keywords: CRT; Heart failure; Machine learning; SPECT.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Figures






References
-
- Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics-2022 Update: a report from the American Heart Association. Circulation. 2022;145:e153–639. http://www.ncbi.nlm.nih.gov/pubmed/35078371. - PubMed
-
- Tracy CM, Epstein AE, Darbar D, DiMarco JP, Dunbar SB, Estes NAM, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2012;126:1784–800. http://www.ncbi.nlm.nih.gov/pubmed/22965336. - PubMed
-
- Normand C, Linde C, Singh J, Dickstein K. Indications for cardiac resynchronization therapy: a comparison of the major international guidelines. JACC Heart Fail. Elsevier Inc. 2018;6:308–16. http://www.ncbi.nlm.nih.gov/pubmed/29598935. - PubMed
-
- Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834–40. - PubMed
-
- Delgado V, Van Bommel RJ, Bertini M, Borleffs JCW, Marsan NA, et al. Imaging relative merits of left ventricular dyssynchrony, left ventricular lead position, and myocardial scar to predict long-term survival of ischemic heart failure patients undergoing cardiac resynchronization therapy. 2011. http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.110.945345/DC1. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous